CRNX: Crinetics Pharmaceuticals Inc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 572.06
Enterprise Value ($M) 449.25
Book Value ($M) 168.92
Book Value / Share 5.13
Price / Book 3.21
NCAV ($M) 162.97
NCAV / Share 4.95
Price / NCAV 3.51

Profitability (mra)
Return on Invested Capital (ROIC) -0.44
Return on Assets (ROA) -0.57
Return on Equity (ROE) -0.63

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 16.92

Balance Sheet (mrq) ($M)
Current Assets 177.49
Assets 183.44
Liabilities 14.53
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income -74.95
Net Income -73.81
Earnings Per Share Basic And Diluted -2.42

Cash Flow Statement (mra) ($M)
Cash From Operations -62.03
Cash from Investing 0.22
Cash from Financing 0.22

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-16 13G/A Ra Capital Management, L.p. 1.70 -69.92
02-16 13G/A 5AM Ventures IV, L.P. 4.10 -42.33
02-16 13G/A Versant Venture Capital V, L.P. 5.80 0.00
02-12 13G/A Vivo Capital VIII, LLC 5.50 -18.95
02-12 13G/A Orbimed Advisors Llc 8.36 35.03
02-08 13G/A Fmr Llc 15.00 35.92
02-05 13G/A Struthers Richard Scott 5.10 13.36
02-02 13G BlackRock Inc. 6.40
04-20 13D/A Perceptive Advisors Llc 11.60 41.40

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-03-30 10-K Annual Report – 10-K
2020-11-06 10-Q Quarterly Report – 10-Q
2020-08-07 10-Q Quarterly Report – 10-Q
2020-05-08 10-Q Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-04-12 39,672 194,174 20.43

(click for more detail)

(click for list of largest short owners)

Similar Companies
CRDF – Cardiff Oncology Inc CRIS – Curis, Inc.
CRMD – CorMedix Inc. CRON – Cronos Group Inc.
CRSP – Crispr Therapeutics AG


Financial data and stock pages provided by
Fintel.io